Prestige Consumer Healthcare shares rose 2.0% to $53.02 on Wednesday. The latest filing offers a less tidy headline: revenue grew 6.5% in the three months ended June 30, but gross profit fell 3.0%. More sales arrived. Fewer profit dollars came with them.
That squeeze ran through the income statement. Operating income fell 26.8% to $52.5 million, while net income dropped 38.5% to $29.2 million. Gross margin slid from 56.2% to 51.3%, a five-point haircut in a business selling over-the-counter healthcare products.
Prestige attributes the North American margin decline directly to lower gross margin. Management also points to unfavorable mix internationally, where gross profit as a percentage of revenue fell from 53.9% to 51.3%.
"As a percentage of North American OTC Healthcare revenues, contribution margin decreased to 38.5% during the three months ended June 30, 2026 from 43.0% during the three months ended June 30, 2025, primarily due to the decrease in gross profit margin noted above."
10-Q, Aug. 6, 2026
The plain-English version is that the pressure was not confined to a single line below gross profit. The company says the lower gross margin reduced the contribution it kept from North American sales.
The balance sheet adds a second plot twist. Inventory rose 24.2% to $190.2 million, nearly four times the pace of revenue growth, while operating cash flow fell 10.4% to $70.8 million. Cash dropped to $89.1 million, and Prestige disclosed that investing cash use increased by $1,061.8 million, primarily because of acquisitions.
The acquisition bill came with a large financing change. Prestige said it issued $1,045.0 million of term loans during the period, while investing cash use increased by $1,061.8 million. The financing change coincided with the acquisition-related increase in investing cash use, but the cash balance still ended lower.
"The $1,054.7 million increase in cash provided by financing activities was primarily due to the proceeds from the issuance of term loans of $1,045.0 million under the Term Loan Credit Agreement and a decrease in the repurchase of shares of our common stock in conjunction with our share repurchase program of $34.8 million, partly offset by the payment of debt issuance costs of $22.5 million."
10-Q, Aug. 6, 2026
That leaves Prestige with a business growing at the sales line and contracting at the profit line, alongside a newly enlarged financing structure. The market-value context is 13.6 times earnings, and the company is carrying $930.1 million of net debt, but the filing shows that the changes accompanying sales growth were not limited to the income statement.
One supporting read-through comes from Prestige's retail footprint. Walmart and Amazon accounted for approximately 20% and 15% of gross revenue, respectively, in the company's latest annual disclosure. Their reported revenue growth was 7.1% and 19.6%, respectively, while Prestige's margin compressed in this period.
Prestige's next quarterly report will provide the factual comparison relevant here: whether inventory and gross margin have moved from the June 30 levels alongside the new term loans.
Prestige sold more in the three months ended June 30, but gross margin fell from 56.2% to 51.3%, according to its 10-Q.